Five-year longitudinal assessment (2008 to 2012) of E-101 solution activity against clinical target and antimicrobial-resistant pathogens.
Denys GA, Pillar CM, Sahm DF, O'Hanley P, Stephens JT. Five-year longitudinal assessment (2008 to 2012) of E-101 solution activity against clinical target and antimicrobial-resistant pathogens. Antimicrob Agents Chemother. 2014 Aug; 58(8):4911-4.